ARCHIVES

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985